| 1 |
Celecoxib FDA Label
|
| 2 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2892).
|
| 3 |
ClinicalTrials.gov (NCT05994287) Pain Treatment With Combinations of NSAIDs
|
| 4 |
ClinicalTrials.gov (NCT00112502) Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme
|
| 5 |
ClinicalTrials.gov (NCT00201773) Exemestane With Celecoxib as Neoadjuvant Treatment in Postmenopausal Women With Stage II, III, and IV Breast Cancer
|
| 6 |
ClinicalTrials.gov (NCT00062101) Erlotinib and Celecoxib in Treating Patients With Stage IIIB or Stage IV Recurrent Non-Small Cell Lung Cancer
|
| 7 |
ClinicalTrials.gov (NCT00525096) Exemestane + Celecoxib vs Exemestane + Placebo in Metastatic Breast Cancer
|
| 8 |
ClinicalTrials.gov (NCT01021215) Zileuton With or Without Celecoxib As Chemopreventive Agents in Smokers
|
| 9 |
ClinicalTrials.gov (NCT00030407) Celecoxib and Docetaxel in Treating Patients With Non-Small Cell Lung Cancer
|
| 10 |
ClinicalTrials.gov (NCT02408146) The Effect of Parecoxib Sodium Intravenous Patient-controlled Analgesia in Laparotomic Liver Resection
|
| 11 |
ClinicalTrials.gov (NCT00305643) Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer
|
| 12 |
ClinicalTrials.gov (NCT00177853) Celecoxib, Irinotecan and Concurrent Radiotherapy in Preoperative Pancreatic Cancer
|
| 13 |
ClinicalTrials.gov (NCT00033371) Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis
|
| 14 |
ClinicalTrials.gov (NCT00808743) Prevention of Progression of Duodenal Adenomas in Patients With Familial Adenomatous Polyposis
|
| 15 |
ClinicalTrials.gov (NCT00037817) Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies
|
| 16 |
ClinicalTrials.gov (NCT00081224) Neoadjuvant Celecoxib and Capecitabine Combined With Pelvic Irradiation in Treating Patients With Stage II or Stage III Adenocarcinoma (Cancer) of the Rectum
|
| 17 |
ClinicalTrials.gov (NCT02839694) Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary Metastasectomy
|
| 18 |
ClinicalTrials.gov (NCT00581971) Radiosensitization With Celecoxib and Chemoradiation for Head and Neck Cancer
|
| 19 |
ClinicalTrials.gov (NCT02151448) alphaDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies. U.S. National Institutes of Health.
|
| 20 |
ClinicalTrials.gov (NCT03822520) Clinical Study to Evaluate Effect on QT/QTc Interval After Multiple Dose of Celecoxib
|
| 21 |
ClinicalTrials.gov (NCT04041050) A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm
|
| 22 |
ClinicalTrials.gov (NCT05232461) A Pilot Study to Evaluate the PK Profile of PrimeC-ER Tablets in Healthy Adult Subjects
|
| 23 |
ClinicalTrials.gov (NCT00538031) Cyclophosphamide With or Without Celecoxib in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
|
| 24 |
ClinicalTrials.gov (NCT02030964) N2012-01: Phase 1 Study of Difluoromethylornithine (DFMO) and Celecoxib With Cyclophosphamide/Topotecan
|
| 25 |
ClinicalTrials.gov (NCT03337607) Radial Extracorporeal Shock Wave Therapy for Chronic Non-specific Low Back Pain
|
| 26 |
ClinicalTrials.gov (NCT01017380) Preemptive Analgesia in Cruciate Reconstruction
|
| 27 |
ClinicalTrials.gov (NCT02115074) Safety of Fluvastatin-Celebrex Association in Low-grade and High Grade Optico-chiasmatic Gliomas
|
| 28 |
ClinicalTrials.gov (NCT00068653) Gefitinib and Celecoxib in Treating Patients With Refractory Non-Small Cell Lung Cancer
|
| 29 |
ClinicalTrials.gov (NCT02602509) Evaluating Celecoxib Activity in Mycobacterium Tuberculosis: A Whole Blood Bactericidal Activity Study in Healthy Volunteers
|
| 30 |
ClinicalTrials.gov (NCT00504660) 6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients
|
| 31 |
ClinicalTrials.gov (NCT00520845) Celecoxib and Docetaxel or Pemetrexed in Treating Patients With Advanced Recurrent Non-Small Cell Lung Cancer
|
| 32 |
ClinicalTrials.gov (NCT02934191) Celecoxib After Tonsillectomy
|
| 33 |
ClinicalTrials.gov (NCT00256321) Celecoxib/Oxaliplatin/Capecitabine for Gastric/Gastroesophageal Junction Carcinoma
|
| 34 |
ClinicalTrials.gov (NCT05077332) LEAP-CT for Treatment of COVID-19 Patients (Master Protocol)
|
| 35 |
ClinicalTrials.gov (NCT02108366) Treatment of Severe Influenza A Infection
|
| 36 |
ClinicalTrials.gov (NCT02703363) Minocycline and Celecoxib as Adjunctive Treatments of Bipolar Depression
|
| 37 |
ClinicalTrials.gov (NCT03121963) Pain Management in Head and Neck Surgery Patients
|
| 38 |
ClinicalTrials.gov (NCT02351934) Early Diuresis Following Colorectal Surgery
|
| 39 |
ClinicalTrials.gov (NCT02703259) Single Dose Preoperative Gabapentin Use in Minimally Invasive Hysterectomy for Acute Pain Management
|
| 40 |
ClinicalTrials.gov (NCT02638896) Dose Reduction of Etanercept in Patients With Ankylosing Spondylitis
|
| 41 |
ClinicalTrials.gov (NCT02739035) MUA to Treat Postoperative Stiffness After Total Knee Arthroplasty
|
|
|
|
|
|
|
